Patent

SPC’s 10 exemplary cases: plant variety rights protection

China’s Supreme People’s Court on March 31 released a second list of exemplary cases, including 2 criminal cases and 8 civil cases. The 10 cases are meant to follow up the first list of 10 exemplary cases released by the top court on September 7, 2021. The fourth Amendments to the Seed Law of t

6 invalidation requests to watch: Chinese companies challenge global pharmaceutical giants’ patents

Patent linkage was introduced into the 4th amendment to the Patent Law of the People’s Republic of China effective June 1, 2021. Unprecedentedly, Article 76 of the Patent Law provides a "dual-track" early resolution mechanism for resolving drug patent disputes during the marketing approval

Two US giants Pfizer and Deere bring trade secret and patent infringement cases against Chinese companies

 Case 1:Pfizer, Inc. on February 2 filed a lawsuit with the District Court for the District of Connecticut accusing two former employees of theft of trade secrets for diabetes and obesity treatments. The complaint said Zhong Min and Qiu Xiayang stole the "playbook" and criti

SPC exemplary case: accused infringer’s “original scope” requirement when asserting prior user rights defense

China’s Supreme People’s Court on August 19, 2021 overturned a lower court ruling in favor of Shenzhen Saiyuan Electronics Co., Ltd. (深圳市赛源电子有限公司) in a patent infringement lawsuit filed by it against Dongguan Loyfun Industrial Co., Ltd

China is lead origin of patent filings of COVID-19 vaccines and therapeutics: WIPO report shows

The World Intellectual Property Organization (WIPO) on March 11 published the Patent Landscape Report on COVID-19-related vaccines and therapeutics to assist member states in addressing the COVID-19 pandemic and building back better as part of their sustainable post COVID economi